recurrence-free survival
1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Sep 2, 2026 by Stéphane Bancel · across every show →
Everything said about recurrence-free survival, oldest first
Sep 2, 2026 positive
Bancel: Moderna Phase 3 trial met primary and secondary endpoints at first interim analysis
“What we announced last week is that we met the primary End point of a study, which was recurrence-free survival, i.e. People having the cancer back or dying, that we met, and then to our own surprise, because this was the first interim analysis. This is not th…”